Pulmonary thromboembolism in adults: Experience from a tertiary care center
- PMID: 39734872
- PMCID: PMC11670582
- DOI: 10.1016/j.mjafi.2022.09.011
Pulmonary thromboembolism in adults: Experience from a tertiary care center
Abstract
Background: Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE). We aimed to analyze the risk factors, clinical presentations, evaluation and management strategies as well as outcomes of adult pulmonary thromboembolism cases at a tertiary care center.
Methods: In a retrospective observational study, all consecutive adult pulmonary thromboembolism cases admitted from January 2019 to September 2020 at our center were enrolled in this study.
Results: Forty-eight patients were included in the present study. The commonest presenting features were dyspnea (93.8%) and cough (79.2%). The risk factors included hypertension 11 (23%), diabetes 6 (12%), recent trauma and recent surgery 3 (6%) each, and malignancy in 2 (4%). DVT was present in 12 (25%) cases while history of smoking was significant, 31 present in (64.6%). Tuberculosis was also found to be an important risk factor for PE in 8 (16.7%). The current COVID-19 pandemic has come up as an important risk factor for PTE which was also true in our case with 13 (27%) patients being cases of moderate to severe COVID-19 pneumonia. Electrocardiogram revealed sinus tachycardia (56.25%), precordial lead T-wave changes (6.3%), and S1Q3T3 pattern (16.67%). Diagnosis was confirmed by computed tomographic pulmonary angiography (CTPA) in 81% of cases. Treatment options included low molecular weight heparin (LMWH) in 91%, newer oral anticoagulants (NOACs) in 2% of the patients and thrombolysis was needed in 12.5% of patients. There was no in-hospital mortality; however one patient had major bleeding.
Conclusion: The clinical presentation of PE varied from dyspnea to cough, though the commonest feature of dyspnea remains unchanged compared to prior studies. CTPA has been modality of choice for diagnosis, however few patients with high probability for PTE were diagnosed clinically along with suggestive echocardiography and ECG findings. Thus, a high index of suspicion and timely therapeutic anticoagulation with various agents led to effective management and better outcome in the studied patients.
Keywords: Computed tomographic pulmonary angiography; Deep vein thrombosis; Low molecular weight heparin; Newer oral anticoagulants; Pulmonary embolism; Venous thromboembolism.
© 2022 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.
Similar articles
-
Home versus in-patient treatment for deep vein thrombosis.Cochrane Database Syst Rev. 2018 Jan 9;1(1):CD003076. doi: 10.1002/14651858.CD003076.pub3. Cochrane Database Syst Rev. 2018. PMID: 29315455 Free PMC article.
-
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2. Cochrane Database Syst Rev. 2022. PMID: 36413425 Free PMC article.
-
Pentasaccharides for the prevention of venous thromboembolism.Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3. Cochrane Database Syst Rev. 2016. PMID: 27797404 Free PMC article.
-
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD005259. doi: 10.1002/14651858.CD005259.pub5. Cochrane Database Syst Rev. 2022. PMID: 35993965 Free PMC article.
-
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Nov 08;11:CD010837. doi: 10.1002/14651858.CD010837.pub4. PMID: 28832905 Free PMC article. Updated.
Cited by
-
Unleashing the Blood Clots: Revolutionizing Acute Pulmonary Thromboembolism Management With Endovascular Techniques.Cureus. 2025 Jan 14;17(1):e77419. doi: 10.7759/cureus.77419. eCollection 2025 Jan. Cureus. 2025. PMID: 39949457 Free PMC article.
References
-
- White R.H. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 suppl 1):I4–I8. - PubMed
-
- Raskob G.E., Angchaisuksiri P., Blanco A.N., et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34(11):2363–2371. - PubMed
-
- Kakkar N., Vasishta R.K. Pulmonary embolism in medical patients: an autopsy-based study. Clin Appl Thromb Hemost. 2008;14(2):159–167. - PubMed
-
- Cohen A.T., Agnelli G., Anderson F.A., et al. The VTE Impact Assessment Group in Europe (VITAE) Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemostasis. 2007;98:756–764. - PubMed
LinkOut - more resources
Full Text Sources